Showing results (331-340 of 1,523) with videos related to
Sort By:
Pageof 153
CPT: Pharmacometrics & Systems Pharmacology|April 2, 2025
Mechanistic Physiologically Based Pharmacokinetic Modeling of Dry Powder and Nebulized Formulations of Orally Inhaled TMEM16A Potentiator GDC-6988Rui Zhu, Ian Sorrell, Fang Ma, et al.CPT: Pharmacometrics & Systems Pharmacology|March 20, 2025
Less Is More: Design Considerations for Interactive Pharmacometrics Tools-A Case Study Using the Model Visualization Platform (MVP) AppSteve Choy, Jin Gyu Kim, Julia KorellCPT: Pharmacometrics & Systems Pharmacology|June 15, 2024
Simulating realistic patient profiles from pharmacokinetic models by a machine learning postprocessing correction of residual variabilityChristos Kaikousidis, Robert R Bies, Aristides DokoumetzidisCPT: Pharmacometrics & Systems Pharmacology|June 5, 2024
Joint modeling of monocyte HLA-DR expression trajectories predicts 28-day mortality in severe SARS-CoV-2 patientsGaelle Baudemont, Coralie Tardivon, Guillaume Monneret, et al.CPT: Pharmacometrics & Systems Pharmacology|July 24, 2024
Exposure-response modeling for nausea incidence for cotadutide using a Markov modeling approachHongtao Yu, Sebastian Ueckert, Lina Zhou, et al.CPT: Pharmacometrics & Systems Pharmacology|July 20, 2024
A guide to developing population files for physiologically-based pharmacokinetic modeling in the Simcyp SimulatorLiam Curry, Sarah Alrubia, Frederic Y Bois, et al.CPT: Pharmacometrics & Systems Pharmacology|June 26, 2024
Impact of obesity and roux-en-Y gastric bypass on the pharmacokinetics of (R)- and (S)-omeprazole and intragastric pHLeandro F Pippa, Valvanera Vozmediano, Lieke Mitrov-Winkelmolen, et al.CPT: Pharmacometrics & Systems Pharmacology|May 15, 2024
Elucidating nonlinear pharmacokinetics of telmisartan: Integration of target-mediated drug disposition and OATP1B3-mediated hepatic uptake in a physiologically based modelToshiaki Tsuchitani, Atsuko Tomaru, Yasunori Aoki, et al.CPT: Pharmacometrics & Systems Pharmacology|November 21, 2025
Exposure-Response Analysis for Time-to-Event Data in the Presence of Adaptive Dosing: Efficient Approaches and PitfallsAlexandra Lavalley-Morelle, Félicien Le Louedec, Richard Anziano, et al.CPT: Pharmacometrics & Systems Pharmacology|November 22, 2025
Exposure-Response Modeling of Monthly Migraine Days for Efficacy of Atogepant in Patients With Episodic or Chronic MigraineLouisa Schlachter, Denise Beck, Ramesh R Boinpally, et al.Pageof 153